These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33887)

  • 61. A comparative study of the antacid effect of some commonly consumed foods for hyperacidity in an artificial stomach model.
    Panda V; Shinde P; Deora J; Gupta P
    Complement Ther Med; 2017 Oct; 34():111-115. PubMed ID: 28917362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro buffering capacities of proprietary non-particulate antacids available in New Zealand.
    Watts DW
    Anaesth Intensive Care; 1994 Apr; 22(2):184-6. PubMed ID: 8210023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparative evaluation of liquid antacids commercially available in the United Kingdom.
    Duffy TD; Fawzy SZ; Ireland DS; Rubinstein MH
    J Clin Hosp Pharm; 1982 Mar; 7(1):53-8. PubMed ID: 7096579
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanism for gastric accumulation of meperidine and effect of antacid.
    Trudnowski RJ; Gessner T
    Can Anaesth Soc J; 1980 Sep; 27(5):496-9. PubMed ID: 7448611
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circadian rhythm of urinary pH in man with and without chronic antacid administration.
    Ayres JW; Weidler DJ; MacKichan J; Wagner JG
    Eur J Clin Pharmacol; 1977 Dec; 12(6):415-20. PubMed ID: 23296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Time course and dose dependence of antacid effect on urine pH.
    Gibaldi M; Grundhofer B; Levy G
    J Pharm Sci; 1975 Dec; 64(12):2003-4. PubMed ID: 1512
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evaluation of antacids "in vitro"].
    Alvarez de Saldaña S; de Ramírez AF; Ramírez Mata M
    Rev Gastroenterol Mex; 1978; 43(3):127-30. PubMed ID: 33434
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Gastropulgit gel in medical practice. Report on experiences with a mucosa protective adhesive antacid].
    Nahser J
    ZFA (Stuttgart); 1978 Nov; 54(32):1683-4. PubMed ID: 32683
    [No Abstract]   [Full Text] [Related]  

  • 69. Antacid effects of Chinese herbal prescriptions assessed by a modified artificial stomach model.
    Wu TH; Chen IC; Chen LC
    World J Gastroenterol; 2010 Sep; 16(35):4455-9. PubMed ID: 20845514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Onset of acid-neutralizing action of a calcium/magnesium carbonate-based antacid using an artificial stomach model: an in vitro evaluation.
    Voropaiev M; Nock D
    BMC Gastroenterol; 2021 Mar; 21(1):112. PubMed ID: 33676393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gastric hypersecretion following intraduodenal injection of pancreatic juice or non-absorbable antacid.
    Stacher G; Tea JP; White TT
    Nature; 1966 Dec; 212(5070):1607-8. PubMed ID: 21105536
    [No Abstract]   [Full Text] [Related]  

  • 72. An improved in vitro method for the evaluation of antacids with in vivo relevance.
    van Riet-Nales DA; van Aalst P; de Kaste D; Barends DM
    Eur J Pharm Biopharm; 2002 Mar; 53(2):217-25. PubMed ID: 11880006
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The in vitro buffering capacity of soluble paracetamol.
    Mills DC
    Anaesthesia; 1989 Dec; 44(12):967-9. PubMed ID: 2619019
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Determination of pH in the esophagus and gastric mucosa under direct observation using the endoscope].
    Watanuki T; Ando H; Komuro K; Oara K
    Nihon Rinsho; 1972 Sep; 30(9):1995-9. PubMed ID: 4675423
    [No Abstract]   [Full Text] [Related]  

  • 75. Antacid activity of Laportea aestuans (L.) Chew.
    Christensen CB; Soelberg J; Jäger AK
    J Ethnopharmacol; 2015 Aug; 171():1-3. PubMed ID: 26023029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Concerning the actions and efficacy of different antacids.
    Chen CT; Toung TJ; Nora S; Cameron JL
    Anesthesiology; 1985 Apr; 62(4):544-5. PubMed ID: 3985413
    [No Abstract]   [Full Text] [Related]  

  • 77. A study of antacid buffers; prolonged neutralization.
    HOLBERT JM; NOBLE N; GROTE IW
    J Am Pharm Assoc Am Pharm Assoc; 1948 Jul; 37(7):292-4. PubMed ID: 18884025
    [No Abstract]   [Full Text] [Related]  

  • 78. Buffering capacity of commercially available foods is influenced by composition and initial properties in the context of gastric digestion.
    Mennah-Govela YA; Cai H; Chu J; Kim K; Maborang MK; Sun W; Bornhorst GM
    Food Funct; 2020 Mar; 11(3):2255-2267. PubMed ID: 32101209
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparative study of the buffering capacity of various commercially available gastric antacids.
    HAMMARLUND ER; RISING LW
    J Am Pharm Assoc Am Pharm Assoc; 1949 Nov; 38(11):586-8. PubMed ID: 15406736
    [No Abstract]   [Full Text] [Related]  

  • 80. Objective evaluation of an antacid with unusual properties.
    Beckloff GL; Chapman JH; Shiverdecker P
    J Clin Pharmacol New Drugs; 1972 Jan; 12(1):11-21. PubMed ID: 4480883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.